Frederic Amant

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Pregnancy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Cadron Isabelle; Van Gorp Toon; Timmerman Dirk; Amant Frederic; Waelkens Etienne; Vergote Ignace
Application of proteomics in ovarian cancer: which sample should be used?
Dieudonné A S; Lambrechts D; Claes B; Vandorpe T; Wildiers H; Timmerman D; Billen J; Leunen K; Amant F; Berteloot P; Smeets A; Paridaens R; Weltens C; Van Limbergen E; Van den Bogaert W; Vergote I; Van Huffel S; Christiaens M R; Neven P
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.
Vergote Ignace; Amant Frederic; Neven Patrick
Is it safe to treat endometrial carcinoma endoscopically?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederic Amant (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cadron Isabelle; Van Gorp Toon; Timmerman Dirk; Amant Frederic; Waelkens Etienne; Vergote Ignace
Application of proteomics in ovarian cancer: which sample should be used?
Gynecologic oncology 2009;115(3):497-503.
2009: Dieudonné A S; Lambrechts D; Claes B; Vandorpe T; Wildiers H; Timmerman D; Billen J; Leunen K; Amant F; Berteloot P; Smeets A; Paridaens R; Weltens C; Van Limbergen E; Van den Bogaert W; Vergote I; Van Huffel S; Christiaens M R; Neven P
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.
Breast cancer research and treatment 2009;118(3):531-8.
2009: Vergote Ignace; Amant Frederic; Neven Patrick
Is it safe to treat endometrial carcinoma endoscopically?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5305-7.
2009: Van Calsteren K; de Catte L; Devlieger R; Chai D C; Amant F
Sonographic biometrical normograms and estimation of fetal weight in the baboon (Papio anubis).
Journal of medical primatology 2009;38(5):321-7.
2009: Vandenput Ingrid; Vergote Ignace; Leunen Karin; Berteloot Patrick; Neven Patrick; Amant Frédéric
Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1147-51.
2009: Amant Frédéric; Despierre Evelyn; Vandenput Ingrid
Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer.
Gynecologic oncology 2009;114(2):370; author reply 370.
2009: Vandenput I; Van Calster B; Capoen A; Leunen K; Berteloot P; Neven P; Moerman Ph; Vergote I; Amant F
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
British journal of cancer 2009;101(2):244-9.
2009: Van Calsteren Kristel; Hartmann Dieter; Van Aerschot Leen; Verbesselt Rene; Van Bree Rieta; D'Hooge Rudi; Amant Frédéric
Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring.
Neurotoxicology 2009;30(4):647-57.
2009: Amant Frédéric; Van Calsteren Kristel; Halaska Michael J; Beijnen Jos; Lagae Lieven; Hanssens Myriam; Heyns Liesbeth; Lannoo Lore; Ottevanger Nelleke P; Vanden Bogaert Walter; Ungar Laszlo; Vergote Ignace; du Bois Andreas
Gynecologic cancers in pregnancy: guidelines of an international consensus meeting.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19 Suppl 1():S1-12.
2009: Brouckaert Olivier; Pintens Saskia; Van Belle Vanya; Van Huffel Sabine; Camerlynck Edward; Amant Frédéric; Leunen Karin; Smeets An; Berteloot Patrick; Van Limbergen Erik; Decock Julie; Hendrickx Wouter; Weltens Caroline; Van den Bogaert Walter; Vanden Bempt Isabelle; Drijkoningen Maria; Paridaens Robert; Wildiers Hans; Vergote Ignace; Christiaens Marie-Rose; Neven Patrick
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
Breast cancer research and treatment 2009;115(2):349-58.
2009: Cadron Isabelle; Van Gorp Toon; Amant Frederic; Vergote Ignace; Moerman Philippe; Waelkens Etienne; Daemen Anneleen; Van De Plas Raf; De Moor Bart; Zeillinger Robert
The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Anticancer research 2009;29(4):1039-45.
2009: Vergote Ignace; Amant Frederic; Van Gorp Toon
Role of diaphragmatic surgery in 69 patients with ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(3):481.
2009: Van Holsbeke C; Amant F; Veldman J; De Boodt A; Moerman Ph; Timmerman D
Hyperreactio luteinalis in a spontaneously conceived singleton pregnancy.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(3):371-3.
2009: Amant Frédéric; Coosemans An; Renard Vincent; Everaert Els; Vergote Ignace
Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(2):245-8.
2009: Coosemans A; Van Hove Th; Verbist G; Moons L; Neven P; Moerman Ph; Vergote I; Van Gool S W; Amant F
Wilms' tumour gene 1 (WT1) positivity in endothelial cells surrounding epithelial uterine tumours.
Histopathology 2009;54(3):384-7.
2009: Vandenput I; Van Eygen K; Moerman Ph; Vergote I; Amant F
Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.
European journal of gynaecological oncology 2009;30(3):313-6.
2009: Vandenput I; Vanden Bempt I; Leunen K; Neven P; Berteloot P; Moerman P; Vergote I; Amant F
Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports.
Gynecologic and obstetric investigation 2009;67(1):46-8.
2008: Vergote Ignace; Tsolakidis Dimitris; Mortier Dieter; Neven Patrick; Amant Frederic; Mottaghy Felix; Van Limbergen Erik
Value of positron emission tomography of the para-aortic lymph nodes in cervical carcinoma stage IB2-IIIB.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5654-5; author reply 5655-7.
2008: Coosemans An; Moerman Philippe; Verbist Godelieve; Maes Wim; Neven Patrick; Vergote Ignace; Van Gool Stefaan W; Amant Frédéric
Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
Gynecologic oncology 2008;111(3):502-8.
2008: Verguts Jasper; Vergote Ignace; Amant Frederic; Moerman Philippe; Koninckx Philippe
The addition of 4% oxygen to the CO(2) pneumoperitoneum does not decrease dramatically port site metastases.
Journal of minimally invasive gynecology 2008;15(6):700-3.
2008: Amant Frédéric; Van Calsteren Kristel; Vergote Ignace; Ottevanger Nelleke
Gynecologic oncology in pregnancy.
Critical reviews in oncology/hematology 2008;67(3):187-95.
2008: Mortier D G; Stroobants S; Amant F; Neven P; VAN Limbergen E; Vergote I
Laparoscopic para-aortic lymphadenectomy and positron emission tomography scan as staging procedures in patients with cervical carcinoma stage IB2-IIIB.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(4):723-9.
2008: Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens M R; Drijkoningen M
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Breast cancer research and treatment 2008;110(1):153-9.
2008: Neven Patrick; Brouckaert Olivier; Van Belle Vanya; Vanden Bempt Isabelle; Hendrickx Wouter; Cho Hyonil; Deraedt Karen; Van Calster Ben; Van Huffel Sabine; Moerman Philippe; Amant Frederic; Leunen Karin; Smeets Ann; Wildiers Hans; Paridaens Robert; Vergote Ignace; Christiaens Marie-Rose
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1768-9; author reply 1769-71.
2008: Vergote Ignace; Amant Frederic; Leunen Karin; Cadron Isabelle; Van Gorp Toon; Neven Patrick; Berteloot Patrick
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.
The oncologist 2008;13(4):410-4.
2008: Chia Stephen; Gradishar William; Mauriac Louis; Bines Jose; Amant Frederic; Federico Miriam; Fein Luis; Romieu Gilles; Buzdar Aman; Robertson John F R; Brufsky Adam; Possinger Kurt; Rennie Pamela; Sapunar Francisco; Lowe Elizabeth; Piccart Martine
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1664-70.
2008: Vergote I; van Gorp T; Amant F; Leunen K; Neven P; Berteloot P
Timing of debulking surgery in advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18 Suppl 1():11-9.
2008: Devolder K; Amant F; Neven P; van Gorp T; Leunen K; Vergote I
Role of diaphragmatic surgery in 69 patients with ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(2):363-8.
2008: De Maeyer Leen; Van Limbergen Erik; De Nys Katelijne; Moerman Philippe; Pochet Nathalie; Hendrickx Wouter; Wildiers Hans; Paridaens Robert; Smeets Ann; Christiaens Marie-Rose; Vergote Ignace; Leunen Karin; Amant Frederic; Neven Patrick
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):335-6; author reply 336-8.
2008: Leunen Karin; Drijkoningen Maria; Neven Patrick; Christiaens Maria-Rose; Van Ongeval Chantal; Legius Eric; Amant Frédéric; Berteloot Patrick; Vergote Ignace
Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?
Breast cancer research and treatment 2008;107(1):79-86.
2008: Vergote Ignace; Pouseele Bram; Van Gorp Toon; Vanacker Bernard; Leunen Karin; Cadron Isabelle; Neven Patrick; Amant Frederic
Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients.
Acta obstetricia et gynecologica Scandinavica 2008;87(7):783-7.
2008: Van Calsteren Kristel; Hanssens Myriam; Moerman Philippe; Orye Guy; Bielen Didier; Vergote Ignace; Amant Frederic
Successful conservative treatment of endocervical adenocarcinoma stage Ib1 diagnosed early in pregnancy.
Acta obstetricia et gynecologica Scandinavica 2008;87(2):250-3.
2008: Gevaert Olivier; De Smet Frank; Van Gorp Toon; Pochet Nathalie; Engelen Kristof; Amant Frederic; De Moor Bart; Timmerman Dirk; Vergote Ignace
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation.
BMC cancer 2008;8():18.
2007: Amant F; De Knijf A; Van Calster B; Leunen K; Neven P; Berteloot P; Vergote I; Van Huffel S; Moerman P
Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma.
British journal of cancer 2007;97(9):1194-9.
2007: Van Mieghem T; Leunen K; Pochet N; De Moor B; De Smet F; Amant F; Berteloot P; Timmerman D; Vanden Bempt I; Drijkoningen R; Wildiers H; Paridaens R; Smeets A; Hendrickx W; Van Limbergen E; Christiaens M R; Vergote I; Neven P
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age.
Breast cancer research and treatment 2007;106(1):127-33.
2007: Cadron Isabelle; Van Gorp Toon; Amant Frederic; Leunen Karin; Neven Patrick; Vergote Ignace
Chemotherapy for recurrent cervical cancer.
Gynecologic oncology 2007;107(1 Suppl 1):S113-8.
2007: Amant Frederic; Moerman Philippe; Neven Patrick; Timmerman Dirk; Van Limbergen Erik; Vergote Ignace
Treatment modalities in endometrial cancer.
Current opinion in oncology 2007;19(5):479-85.
2007: Cadron Isabelle; Leunen Karin; Amant Frédéric; Van Gorp Toon; Neven Patrick; Vergote Ignace
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer.
Gynecologic oncology 2007;106(2):354-61.
2007: Cadron Isabelle; Leunen Karin; Van Gorp Toon; Amant Frederic; Neven Patrick; Vergote Ignace
Management of borderline ovarian neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(20):2928-37.
2007: Coosemans A; Nik S Amini; Caluwaerts S; Lambin S; Verbist G; Van Bree R; Schelfhout V; de Jonge E; Dalle I; Jacomen G; Cassiman J J; Moerman Ph; Vergote I; Amant F
Upregulation of Wilms' tumour gene 1 (WT1) in uterine sarcomas.
European journal of cancer (Oxford, England : 1990) 2007;43(10):1630-7.
2007: Morales Leilani; Pans Steven; Paridaens Robert; Westhovens Rene; Timmerman Dirk; Verhaeghe Johan; Wildiers Hans; Leunen Karin; Amant Frederic; Berteloot Patrick; Smeets Ann; Van Limbergen Erik; Weltens Caroline; Van den Bogaert Walter; De Smet Luc; Vergote Ignace; Christiaens Marie-Rose; Neven Patrick
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging.
Breast cancer research and treatment 2007;104(1):87-91.
2007: Van den Bosch T; Van Schoubroeck D; Domali E; Vergote I; Moerman P; Amant F; Timmerman D
A thin and regular endometrium on ultrasound is very unlikely in patients with endometrial malignancy.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(6):674-9.
2007: Lannoo L; Smets S; Steenkiste E; Delforge M; Moerman P; Stroobants S; Knockaert D; Amant F
Intravascular large B-cell lymphoma of the uterus presenting as fever of unknown origin (FUO) and revealed by FDG-PET.
Acta clinica Belgica 2007;62(3):187-90.
2007: Van Calster B; Timmerman D; Lu C; Suykens J A K; Valentin L; Van Holsbeke C; Amant F; Vergote I; Van Huffel S
Preoperative diagnosis of ovarian tumors using Bayesian kernel-based methods.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):496-504.
2007: Kalogiannidis Ioannis; Lambrechts Sandrijne; Amant Frederic; Neven Patrick; Van Gorp Toon; Vergote Ignace
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome.
American journal of obstetrics and gynecology 2007;196(3):248.e1-8.
2007: Vandenput I; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(1):83-7.
2007: Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer.
Cancer treatment and research 2007;134():387-402.
2006: Amant Frederic; Woestenborghs Heidi; Vandenbroucke Vanessa; Berteloot Patrick; Neven Patrick; Moerman Philippe; Vergote Ignace
Transition of endometrial stromal sarcoma into high-grade sarcoma.
Gynecologic oncology 2006;103(3):1137-40.
2006: Wildiers Hans; Neven Patrick; Amant Frederic; D'hooghe Thomas; Paridaens Robert
Fertility preservation in (breast) cancer patients: is it safe?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5335-6; author reply 5337-8.
2006: Colombo Nicoletta; Van Gorp Toon; Parma Gabriella; Amant Frederic; Gatta Gemma; Sessa Cristiana; Vergote Ignace
Ovarian cancer.
Critical reviews in oncology/hematology 2006;60(2):159-79.
2006: Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Minerva ginecologica 2006;58(5):393-403.
2006: Marquette Sophie; Amant Frederic; Vergote Ignace; Moerman Philippe
Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2006;25(4):340-3.
2006: Van Gorp T; Vergote I B; Pochet N L M M; Amant F
Methodology in plasma proteomic pattern experiments.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1951-2; author reply 1953.
2006: Kalogiannidis I; Lambrechts S; Amant F; Neven P; VAN Limbergen E; Vergote I
Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(5):1885-93.
2006: Vergote Ignace; Amant Frederic
Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
Gynecologic oncology 2006;102(3):415-7.
2006: Vandenput Ingrid; Vergote Ignace; Amant Frederic; Neven Patrick; Paridaens Robert; Christiaens Marie-Rose
Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling.
The breast journal 2006;12(5):507-8.
2006: Cadron Isabelle; Amant Frederic; Van Gorp Toon; Neven Patrick; Leunen Karin; Vergote Ignace
The management of borderline tumours of the ovary.
Current opinion in oncology 2006;18(5):488-93.
2006: Gevaert Olivier; Pochet Nathalie; De Smet Frank; Van Gorp Toon; De Moor Bart; Timmerman Dirk; Amant Frédéric; Vergote Ignace
Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practice.
International journal of cancer. Journal international du cancer 2006;119(6):1511; author reply 1512.
2006: Bergeron Christine; Amant Frederic; Ferenczy Alex
Pathology and physiopathology of adenomyosis.
Best practice & research. Clinical obstetrics & gynaecology 2006;20(4):511-21.
2006: Van Calsteren Kristel; Van Mensel Kristin; Joniau Steven; Oyen Raymond; Hanssens Myriam; Amant Frederic; Van Poppel Hendrik
Urachal carcinoma during pregnancy.
Urology 2006;67(6):1290.e19-21.
2006: Neven Patrick; Pochet Nathalie; Drijkoningen Maria; Amant Frederic; De Smet Frank; Paridaens Robert; Christiaens Marie-Rose; Vergote Ignace
Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2595; author reply 2595-7.
2006: De Smet F; De Brabanter J; Van den Bosch T; Pochet N; Amant F; Van Holsbeke C; Moerman P; De Moor B; Vergote I; Timmerman D
New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2006;27(6):664-71.
2006: Marquette A; Moerman P; Vergote I; Amant F
Second case of uterine mesonephric adenocarcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):1450-4.
2006: Van Calsteren Kristel; Berteloot Patrick; Hanssens Myriam; Vergote Ignace; Amant Frederic; Ganame Javier; Claus Piet; Mertens Luc; Lagae Lieven; Delforge Michel; Paridaens Robert; Noens Lucien; Humblet Yves; Vandermeersch Bruno; De Muylder Xavier
In utero exposure to chemotherapy: effect on cardiac and neurologic outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):e16-7.
2006: Caluwaerts S; VAN Calsteren K; Mertens L; Lagae L; Moerman P; Hanssens M; Wuyts K; Vergote I; Amant F
Neoadjuvant chemotherapy followed by radical hysterectomy for invasive cervical cancer diagnosed during pregnancy: report of a case and review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(2):905-8.
2006: Despierre E; Moerman P; Vergote I; Amant F
Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():273-7.
2006: De Smet F; Pochet N L M M; Engelen K; Van Gorp T; Van Hummelen P; Marchal K; Amant F; Timmerman D; De Moor B L R; Vergote I B
Predicting the clinical behavior of ovarian cancer from gene expression profiles.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():147-51.
2006: Fuso L; Amant F; Neven P; Berteloot P; Vergote I
Gemcitabine-carboplatin-paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():60-7.
2006: Leunen K; Legius E; Moerman P; Amant F; Neven P; Vergote I
Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):183-8.
2006: Amant F; Leunen K; Neven P; Berteloot P; Vergote I
Endometrial cancer: predictors of response and preferred endocrine therapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():527-8.
2006: Vergote I; Amant F; Leunen K; Van Gorp T; Berteloot P; Neven P
Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():524-6.
2006: Neven P; Paridaens R; Amant F; Wildiers H; Berteloot P; Leunen K; Smeets A; Weltens C; van den Bogaert W; van Limbergen E; Christiaens M R; Vergote I
Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():505-10.
2006: Neven P; Vergote I; Amant F; Berteloot P; de Jonge E; DE Rop C; DE Sutter P; Makar A; VAN Ginderachter J
Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 2():479-91.
2006: Amant F; Vandenput I; Van Gorp T; Vergote I; Moerman Ph
Endometrial carcinosarcoma with osteoclast-like giant cells.
European journal of gynaecological oncology 2006;27(1):92-4.
2005: Amant Frederic
Different subtypes of uterine sarcoma require a separate therapeutic approach.
Women's health (London, England) 2005;1(3):375-83.
2005: Vergote Ignace; van Gorp Toon; Amant Frederic; Neven Patrick; Berteloot Patrick
Neoadjuvant chemotherapy for ovarian cancer.
Oncology (Williston Park, N.Y.) 2005;19(12):1615-22; discussion 1623-30.
2005: Amant F; Moerman P; Vergote I
Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1210-2.
2005: Fruscella E; Testa A C; Ferrandina G; De Smet F; Van Holsbeke C; Scambia G; Zannoni G F; Ludovisi M; Achten R; Amant F; Vergote I; Timmerman D
Ultrasound features of different histopathological subtypes of borderline ovarian tumors.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2005;26(6):644-50.
2005: Van Mieghem Tim; Abeler Vera M; Moerman Philippe; Verbist Lieve; Vergote Ignace; Amant Frederic
CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
Gynecologic oncology 2005;99(2):493-6.
2005: Amant Frederic
The rationale for comprehensive surgical staging in endometrial carcinosarcoma.
Gynecologic oncology 2005;99(2):521-2; author reply 522-3.
2005: Caluwaerts S; Amant F; Vergote I
Role of cyclin-dependent kinase p27 in uterine carcinosarcomas.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(5):986-7; author reply 988.
2005: Van Calsteren K; Amant F; Vergote I
Role of adnexectomy in the surgical treatment of cervical adenocarcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(5):984; author reply 985.
2005: Vergote I; Marquette S; Amant F; Berteloot P; Neven P
Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(5):776-9.
2005: Vandenput I; Amant F; Vergote I
Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy.
Gynecologic oncology 2005;98(3):523; author reply 524-5.
2005: Amant Frederic; Moerman Philippe; Neven Patrick; Timmerman Dirk; Van Limbergen Erik; Vergote Ignace
Endometrial cancer.
Lancet 2005;366(9484):491-505.
2005: Amant Frederic; Cadron Isabelle; Fuso Luca; Berteloot Patrick; de Jonge Eric; Jacomen Gerd; Van Robaeys Johan; Neven Patrick; Moerman Philippe; Vergote Ignace
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Gynecologic oncology 2005;98(2):274-80.
2005: Van Calsteren K; Vergote I; Amant F
Cervical neoplasia during pregnancy: diagnosis, management and prognosis.
Best practice & research. Clinical obstetrics & gynaecology 2005;19(4):611-30.
2005: De Greef Ingrid; Berteloot Patrick; Timmerman Dirk; Deprest Jan; Amant Frederic
Viable cervical pregnancy with levonorgestrel containing intrauterine device, treated successfully with methotrexate and mifepristone.
European journal of obstetrics, gynecology, and reproductive biology 2005;120(2):233-5.
2005: Huang H J; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens M R
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
Journal of clinical pathology 2005;58(6):611-6.
2005: Huang Huei-Jean; Neven Patrick; Drijkoningen Maria; Paridaens Robert; Wildiers Hans; Van Limbergen Erik; Berteloot Patrick; Amant Frederic; Christiaens Marie Rose; Vergote Ignace
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
Breast cancer research and treatment 2005;91(1):81-7.
2004: Amant Frederic; Vloeberghs Veerle; Woestenborghs Heidi; Debiec-Rychter Maria; Verbist Lieve; Moerman Philippe; Vergote Ignace
ERBB-2 gene overexpression and amplification in uterine sarcomas.
Gynecologic oncology 2004;95(3):583-7.
2004: Amant F; Steenkiste E; Schurmans K; Verbist L; Abeler V M; Tulunay G; de Jonge E; Massuger L; Moerman P; Vergote I
Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(6):1118-21.
2004: Amant Frederic; Vergote I; Moerman Ph
The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned.
Gynecologic oncology 2004;95(2):412-3; author reply 413.
2004: Amant Frederic; Schurmans Katrien; Steenkiste Edwin; Verbist Lieve; Abeler Vera M; Tulunay Gökhan; De Jonge Eric; Massuger Leon; Moerman Philippe; Vergote Ignace
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Gynecologic oncology 2004;93(3):680-5.
2004: Van Gorp Toon; Amant Frederic; Neven Patrick; Vergote Ignace; Moerman Phillipe
Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
Best practice & research. Clinical obstetrics & gynaecology 2004;18(2):349-71.
2004: Amant Frederic; Vergote Ignace
Importance of the endometrioid carcinoma subtype and sarcomatous component in uterine carcinosarcoma.
Gynecologic oncology 2004;93(1):272-3; author reply 273-4.
2004: Amant Frédéric; Dorfling Cecilia M; de Brabanter Jos; Vandewalle Joos; Vergote Ignace; Lindeque B G; van Rensburg Elizabeth J
A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study.
Acta obstetricia et gynecologica Scandinavica 2004;83(3):234-9.
2003: Amant Frederic; Lottering Mona Liza; Joubert Annie; Thaver Veneesha; Vergote Ignace; Lindeque B G
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth.
Gynecologic oncology 2003;91(2):299-308.
2003: Leunen Karin; Amant Frederic; Debiec-Rychter Maria; Croes Romaric; Hagemeijer Anne; Schoenmakers Eric F P M; Vergote Ignace
Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation.
Gynecologic oncology 2003;91(1):265-71.
2003: Amant Frederic; Vloeberghs Veerle; Woestenborghs Heidi; Moerman Philippe; Vergote Ignace
Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.
Gynecologic oncology 2003;90(2):372-7.
2003: Amant Frédéric; Moerman Philippe; Cadron Isabelle; Neven Patrick; Berteloot Patrick; Vergote Ignace
The diagnostic problem of endometrial stromal sarcoma: report on six cases.
Gynecologic oncology 2003;90(1):37-43.
2003: Amant Frédéric; Vergote Ignace
Bifunctional pathway of uterine carcinosarcomas.
Human pathology 2003;34(3):299; author reply 300.
2003: Amant Frédéric; Gabriel Charlotte; Moerman Philippe; Vergote Ignace
Immunohistochemical determination of hormone receptors in uterine adenosarcomas.
Gynecologic oncology 2003;88(3):463-4.
2003: Amant Frédéric; Moerman Philippe; Cadron Isabelle; Hagemeijer Anne; Vergote Ignace; Debiec-Rychter Maria
Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.
Gynecologic oncology 2003;88(3):459-62.
2003: D'Agostino Giuseppe; Amant Frederic; Berteloot Patrick; Scambia Giovanni; Vergote Ignace
Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.
Gynecologic oncology 2003;88(3):266-9.
2003: Amant Frédéric; Huys Erik; Geurts-Moespot Anneke; Lindeque B G; Vergote Ignace; Sweep Fred; Schoenmakers Eric F P M
Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.
Journal of the Society for Gynecologic Investigation 2003;10(2):105-9.
2002: Amant Frederic; Vergote Ignace
PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.
American journal of obstetrics and gynecology 2002;187(1):258.
2002: Amant F; de la Rey M; Dorfling C M; van der Walt L; Dreyer G; Dreyer L; Vergote I; Lindeque B G; Van Rensburg E J
PTEN mutations in uterine sarcomas.
Gynecologic oncology 2002;85(1):165-9.
2002: Vergote Ignace; De Smet Isabel; Amant Frédéric
Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Gynecologic oncology 2002;84(3):537-8.
2002: Vergote Ignace; Amant F; Berteloot P; Van Gramberen M
Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(1):22-6.
2001: Amant F; Debiec-Rychter M; Schoenmakers E F; Hagemeijer-Hausman A; Vergote I
Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome.
Genes, chromosomes & cancer 2001;32(4):324-9.
2001: Amant F; Gabriel C; Timmerman D; Vergote I
Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125.
Gynecologic oncology 2001;83(1):153-7.
2001: Amant F; Dorfling C M; Dreyer L; Vergote I; Lindeque B G; Van Rensburg E J
Microsatellite instability in uterine sarcomas.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(3):218-23.
2001: Amant F; Moerman P; Davel G H; De Vos R; Vergote I; Lindeque B G; de Jonge E
Uterine carcinosarcoma with melanocytic differentiation.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2001;20(2):186-90.
2001: Amant F; Dreyer L; Makin J; Vergote I; Lindeque B G
Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations.
European journal of gynaecological oncology 2001;22(3):194-200.
1999: Amant F; Spitz B; Timmerman D; Corremans A; Van Assche F A
Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.
British journal of obstetrics and gynaecology 1999;106(10):1066-70.
1999: Timmerman D; Schwärzler P; Collins W P; Claerhout F; Coenen M; Amant F; Vergote I; Bourne T H
Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 1999;13(1):11-6.
1998: Amant F; Berteloot P; Vergote I
Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes in ovarian cancer surgery.
Gynecologic oncology 1998;71(3):348-51.
1997: Amant F; Spitz B; Arnout J; Van Assche F A
Hepatic necrosis and haemorrhage in pregnant patients with antiphospholipid antibodies.
Lupus 1997;6(6):552-5.
1995: Van Hoe L; Gryspeerdt S; Amant F; Marchal G; Baert A L; Spitz B
Abdominal pain in the postpartum: role of imaging.
Journal belge de radiologie 1995;78(3):186-9.
1989: Missiaen L; Wuytack F; De Smedt H; Amant F; Casteels R
AIF4-induced inhibition of the ATPase activity, the Ca2+-transport activity and the phosphoprotein-intermediate formation of plasma-membrane and endo(sarco)plasmic-reticulum Ca2+-transport ATPases in different tissues. Evidence for a tissue-dependent functional difference.
The Biochemical journal 1989;261(2):655-60.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Frederic Amant

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Frederic Amant (preview)

All Publications